Table 1.
Characteristics of patients by cancer type
| Breast | Colorectal | Liver | Lung | Ovary | Pancreas | Prostate | All | |
| Age (yr) | 42.6 ± 5.3 | 42.2 ± 6.2 | 43.4 ± 6.1 | 44.0 ± 5.1 | 40.5 ± 7.5 | 43.5 ± 5.4 | 46.4 ± 2.8 | 43.0 ± 5.6 |
| Sex | ||||||||
| Female | 99.6% | 48.3% | 22.2% | 46.0% | 100.0% | 42.3% | 0.0% | 75.6% |
| Male | 0.4% | 51.7% | 77.8% | 54.0% | 0.0% | 57.7% | 100.0% | 24.4% |
| Race | ||||||||
| White | 75.8% | 72.7% | 61.0% | 73.8% | 77.9% | 74.5% | 68.4% | 74.3% |
| Black | 12.9% | 16.3% | 14.9% | 18.4% | 9.4% | 16.6% | 25.9% | 15.0% |
| Other | 10.5% | 10.0% | 23.6% | 7.5% | 12.0% | 8.5% | 2.9% | 9.9% |
| Unknown | 0.8% | 0.9% | 0.5% | 0.3% | 0.7% | 0.4% | 2.8% | 0.9% |
| Year of diagnosis | ||||||||
| 1990-1994 | 9.8% | 8.9% | 7.9% | 13.1% | 12.1% | 9.1% | 3.6% | 9.7% |
| 1995-1999 | 12.7% | 11.4% | 13.5% | 13.9% | 13.6% | 12.4% | 9.2% | 12.5% |
| 2000-2004 | 28.8% | 28.8% | 31.4% | 31.4% | 29.0% | 28.7% | 29.6% | 29.3% |
| 2005-2012 | 48.8% | 50.8% | 47.3% | 41.6% | 45.4% | 49.7% | 57.6% | 48.5% |
| Surgery | ||||||||
| No | 3.8% | 7.8% | 63.5% | 63.1% | 5.4% | 61.8% | 23.4% | 17.0% |
| Yes | 94.2% | 89.7% | 23.5% | 26.9% | 92.1% | 28.2% | 68.2% | 78.8% |
| Unknown | 2.1% | 2.4% | 13.0% | 10.0% | 2.5% | 9.9% | 8.4% | 4.2% |
| Stage | ||||||||
| Local | 53.3% | 29.2% | 33.9% | 11.6% | 35.6% | 8.8% | 90.7% | 45.3% |
| Regional | 38.7% | 37.2% | 27.2% | 22.8% | 8.5% | 26.3% | 0.0% | 31.2% |
| Distant | 6.1% | 29.1% | 21.5% | 58.7% | 50.6% | 57.3% | 3.4% | 19.5% |
| Unstaged | 2.0% | 4.5% | 17.3% | 6.9% | 5.3% | 7.7% | 5.9% | 4.0% |
| Radiation | ||||||||
| None | 47.8% | 94.0% | 91.0% | 46.7% | 97.1% | 76.1% | 79.3% | 59.7% |
| Beam | 47.0% | 4.1% | 4.6% | 48.9% | 1.6% | 20.3% | 10.5% | 35.4% |
| Other | 0.7% | 0.1% | 1.0% | 0.4% | 0.2% | 0.2% | 8.0% | 1.1% |
| Unknown | 4.4% | 1.9% | 3.4% | 4.0% | 1.1% | 3.4% | 2.3% | 3.7% |